Home › Research › TREM2 and immune genetics
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease
Henjum K, Almdahl IS, Årskog V, Minthon L, Hansson O, Fladby T, Nilsson LN.. Alzheimer's research & therapy, 2016-04-27
Topic: Brain proteins, microglia and lab models
Plain-language summary
Background Alzheimer's disease (AD) neuropathology is associated with neuroinflammation, but there are few useful biomarkers. Mutant variants of triggering receptor expressed on myeloid cells 2 (TREM2) have recently been linked to late-onset AD and other neurodegenerative disorders. TREM2, a microglial receptor, is involved in innate immunity.
What this study adds
Evidence grade: Moderate
The record lists 100 participants. The stored summary ends before the results, so it does not say whether levels differed between groups. It is a measurement study and does not test any treatment.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Henjum, K., Almdahl, I. S., Årskog, V., Minthon, L., Hansson, O., Fladby, T., et al. (2016). Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease. Alzheimer's research & therapy. https://doi.org/10.1186/s13195-016-0182-1
Vancouver
Henjum K, Almdahl IS, Årskog V, Minthon L, Hansson O, Fladby T, et al. Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease. Alzheimer's research & therapy. 2016. doi:10.1186/s13195-016-0182-1. PMID: 27121148.
BibTeX
@article{henjum2016-27121148,
author = {Henjum, K. and Almdahl, I. S. and Årskog, V. and Minthon, L. and Hansson, O. and Fladby, T. and Nilsson, L. N.},
title = {{Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease}},
journal = {Alzheimer's research \& therapy},
year = {2016},
doi = {10.1186/s13195-016-0182-1},
pmid = {27121148},
url = {https://doi.org/10.1186/s13195-016-0182-1}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Mutant variants of triggering receptor expressed on myeloid cells 2 (TREM2) have recently been linked to late-onset AD and other neurodegenerative disorders.
- TREM2, a microglial receptor, is involved in innate immunity.
- A cleaved fragment, soluble TREM2 (sTREM2), is present in the cerebrospinal fluid (CSF).
- Methods We developed and used a novel enzyme-linked immunosorbent assay to investigate the potential value of CSF sTREM2 as an AD biomarker in two independent cohorts: an AD/mild cognitive impairment (MCI)/control cohort (n = 100) and an AD/control cohort (n = 50).
Why it matters
This study built a new lab test (an ELISA) for soluble TREM2, a fragment of a microglial immune receptor found in spinal fluid, and used it to look at whether it could serve as an Alzheimer's biomarker in two groups: 100 people with Alzheimer's, mild cognitive impairment or in a control group, and a further 50 people with Alzheimer's or in a control group. The stored summary ends before the results, so it does not say whether levels differed between groups. It is a measurement study and does not test any treatment.
New to this subject? Start with our plain-English guide: Genetics →
Study details
- Participants100
- Evidence strengthModerate
How this study scored 54/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer's research & therapy) |
| Journal's citation record | 1 / 4 | Alzheimer s Research & Therapy: journal h-index 146 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2016 — within 20 year(s) of the newest study here |
| Sample size | 2 / 4 | 100 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 5 / 7 | Cited 144 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 12.0 citations a year over 12 year(s) since 2016 |
| Impact for its field and year | 4 / 6 | Cited 10.3× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 4 / 6 | Cited by 38 other studies in this library |
| Still being cited | 2 / 4 | Cited 39 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Lars N. G. Nilsson: h-index 37 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Lund University: institution h-index 1,119 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 4 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 27121148) |
| Free to read | 2 / 2 | Free to read |
| Total | 54 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1186/s13195-016-0182-1
- PubMed: 27121148
- Original source →
- Free full text: Alzheimer s Research & Therapy →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 36.
Later studies that cite this one
38 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in TREM2 and immune genetics from nearby years
Also tagged “r47h”
363 studies in the library carry the topic tag “r47h”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 363 tagged studies.